Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Cognitive Impairment

Cognition and Cognitive Testing

As noted above, the diagnoses of mild cognitive impairment and dementia of the Alzheimer type both require the presence of memory impairment. To distinguish between MCI and DAT, it is important to determine the degree and course of memory impairment, the presence or absence of additional domains of cognitive dysfunction, and the impact of… Cognition and Cognitive Testing   



Mayo Clinic Physician to Head HHS Council on Alzheimer’s Disease

Ronald Petersen, M.D., Cadieux Director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging, was selected to chair the Advisory Council on Alzheimer’s Research, Care, and Services. The group was announced by Health and Human Services (HHS) Secretary Kathleen Sebelius.

The 12 non-federal council members include Alzheimer’s disease patient… Mayo Clinic Physician to Head HHS Council on Alzheimer’s Disease   



Inflammatory mediator enhances plaque formation in Alzheimer’s disease

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that causes progressive cognitive impairment and memory loss. Now, a new study published by Cell Press in the September 8 issue of the journal Neuron identifies a previously unrecognized link between neuroinflammation and the classical pathological brain changes that are the hallmark of the disease. In… Inflammatory mediator enhances plaque formation in Alzheimer’s disease   



Blood Vessel Disease of Retina May be Marker of Cognitive Decline

Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).

The findings suggest that a relatively simple… Blood Vessel Disease of Retina May be Marker of Cognitive Decline   



Dementia Risk Seen in Study Refusers

People who declined to participate in a prospective study of aging developed dementia more quickly than those who joined the study, a researcher said here, suggesting study participants may not be a representative sample.

Among participants in the study, dementia was diagnosed at a rate of 19.1 per 1,000 person-years, compared with 23.6 per… Dementia Risk Seen in Study Refusers   



Amyloid imaging helps in evaluating possible Alzheimer disease

A test to detect brain amyloid deposits associated with Alzheimer disease (AD) provides doctors with useful information on treatment and further testing for patients with cognitive impairment, according to a study published online by the journal Alzheimer Disease & Associated Disorders. The journal is published by Lippincott Williams & Wilkins, a part ofWolters Kluwer… Amyloid imaging helps in evaluating possible Alzheimer disease   



Hearing loss may be related to cognitive decline in older adults

Hearing loss appears to be associated with accelerated cognitive decline and cognitive impairment in a study of older adults, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

The prevalence of dementia is projected to double every 20 years because of the world’s aging population so identifying the… Hearing loss may be related to cognitive decline in older adults   



Self-administered test helps spot early Alzheimer’s

The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes to complete, is a reliable tool for evaluating cognitive abilities. Findings by researchers at The Ohio State University Wexner Medical Center confirming the feasibility and efficiency of the tool for community screening large numbers of people are published in the January issue… Self-administered test helps spot early Alzheimer’s   



Potential Alzheimer’s disease risk factor and risk reduction strategies become clearer

Participation in activities that promote mental activity, and moderate physical activity in middle age, may help protect against the development of Alzheimer’s disease and dementia in later life, according to new research reported today at the Alzheimer’s Association International Conference® 2014 (AAIC® 2014) in Copenhagen.

Research reported at AAIC 2014 also showed that sleep… Potential Alzheimer’s disease risk factor and risk reduction strategies become clearer   



Moffitt researchers say androgen deprivation therapy may lead to cognitive impairment

Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is commonly called “chemo brain.” Signs of cognitive impairment include forgetfulness, inability to concentrate, problems recalling information, trouble multi-tasking and becoming slower at processing information. The number… Moffitt researchers say androgen deprivation therapy may lead to cognitive impairment   



Enid and George - Life with dementia

common form of dementia1 - phosphorylated tau1 - anticholinergics1 - stroke risk factors1 - diabetes10 - pomegranate1 - frontal lobe pathology1 - mini-strokes2 - anoea1 - sinequan1 - heart attack2 - historical hypotheses1 - arts health institute1 - the journal of neuroscience1 - amyloid beta protein2 - risk of stroke1 - amyloid-beta peptides1 - heart health risk1 - age-related cognitive disorders1 - dementia progression1 - muscle co-ordination1 - korsakoff psychosis11 - physical weakness1 - micro-gliosis1 - long-term memory1 - tetrahydrocannabinol1 - memory losses1 - diagnosis of dementia1 - alzheimer treatment1 - mri2 -